Patent Update: Angiotensin-II Antagonists: Patent Activity since the Discovery of DuP-753-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patent Update: Angiotensin-II Antagonists: Patent Activity since the Discovery of DuP-753

Published:1992-10 Issue:10 Volume:2 Page:1693-1718
ISSN:0962-2594
Container-title:Current Opinion on Therapeutic Patents
language:en
Short-container-title:Current Opinion on Therapeutic Patents

Author:

Bühlmayer Peter

Publisher

Informa Healthcare

Subject

Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/13543776.2.10.1693

Reference52 articles.

2. Effects of Enalapril on Mortality in Severe Congestive Heart Failure

3. Purification and characterization of human converting enzyme (kininase II)

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT1 Angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies;Journal of Computer-Aided Molecular Design;2010-07-10

2. How the antihypertensive losartan was discovered;Expert Opinion on Drug Discovery;2006-11

3. Synthesis, binding studies and in vivo biological evaluation of novel non-peptide antihypertensive analogues;Bioorganic & Medicinal Chemistry;2006-07

4. 5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods;Bioorganic & Medicinal Chemistry;2002-11

5. Losartan: a selective angiotensin II type 1 (AT1) receptor antagonist for the treatment of heart failure;Expert Opinion on Investigational Drugs;1998-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3